Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in Korea

Study Identifier
206207-029
CT.gov Identifier
NCT01976650
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • dexamethasone 700 ㎍ intravitreal implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Patients with Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, or non-infectious uveitis affecting the posterior segment of the eye treated with (OZURDEX®) in clinical practice.
    Exclusion Criteria:
    * Patients with eye infections * Patients with glaucoma.

    Protocol Summary

    This study is a Post-Market Surveillance study in Korea to evaluate the safety and efficacy of dexamethasone 700 ㎍ (OZURDEX®) intravitreal implant used to treat Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, or non-infectious uveitis affecting the posterior segment of the eye in clinical practice.

    Study Locations

    Location
    Status
    Location
    Seoul, Republic of Korea
    Status
    Not applicable